Skip to main content
. 2023 Oct 16;29(11):2919–2928. doi: 10.1038/s41591-023-02603-1

Fig. 3. Resmetirom-mediated changes in markers of liver injury and sex-hormone bindingglobulin.

Fig. 3

ad, Mean ALT (a), AST (b) and GGT (c) in the subgroup with baseline ALT levels ≥30 IU l−1 and SHBG (nmol l−1) (d) levels over time. Shown are observed data (100 mg OL n = 83; 100 mg DB n = 157; 80 mg DB n = 169; placebo n = 156). Data are presented as mean ± s.e.m.